The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
A review of uses of health care utilization databases for epidemiologic research on therapeutics
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
The central role of the propensity score in observational studies for causal effects
ROSENBAUM, P. R., & RUBIN, D. B. (1983) · Biometrika · doi:10.1093/biomet/70.1.41 · Cited by 31,241
Longitudinal data analysis using generalized linear models
LIANG, K.-Y., & ZEGER, S. L. (1986) · Biometrika · doi:10.1093/biomet/73.1.13 · Cited by 18,550
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
DEYO, R. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90133-8 · Cited by 10,452 · cited 1×
“The Deyo claims data application [59] of the Charlson comorbidity score [60] that performs well in elderly patients [61] was recorded correctly in more than 40% of patients and misclassified by only one point in an additional 35% of patients when compared with ambulatory medical records [53].”
MethodA simulation study of the number of events per variable in logistic regression analysis
Peduzzi, P., Concato, J., Kemper, E., Holford, T. R., & Feinstein, A. R. (1996) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(96)00236-3 · Cited by 9,655
Hulley, S. (1998) · JAMA · doi:10.1001/jama.280.7.605 · Cited by 6,216
Modern Epidemiology 3rd edition
Rothman, K. J., Lash, T. L., & Greenland, S. (1986) · Cited by 3,097
Estimating Causal Effects from Large Data Sets Using Propensity Scores
Rubin, D. B. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-8_part_2-199710151-00064 · Cited by 2,877
The Case-Crossover Design: A Method for Studying Transient Effects on the Risk of Acute Events
Maclure, M. (1991) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115853 · Cited by 2,327 · cited 1×
“Relevant examples are the case-crossover design [95] and prescription symmetry analysis [96].”
Statins and the risk of dementia
Jick, H., Zornberg, G., Jick, S., Seshadri, S., & Drachman, D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03155-x · Cited by 1,759
Use and misuse of population attributable fractions
Rockhill, B., Newman, B., & Weinberg, C. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.1.15 · Cited by 1,683 · cited 1×
“In population-based databases, it is possible to estimate the proportion of the population exposed and thus the population-attributable risk as a more policy-relevant measure of risk [18].”
BackgroundEvaluating medication effects outside of clinical trials: new-user designs
Ray, W. A. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg231 · Cited by 1,646
Applied Longitudinal Data Analysis for Epidemiology: A Practical Guide
Twisk, J. W. R. (2003) · Cited by 1,466
Methods in Observational Epidemiology
Kelsey, J. L. (1986) · Cited by 1,307
Methods in observational epidemiology
Leck, I. (1987) · Journal of Epidemiology and Community Health · doi:10.1136/jech.41.3.263-a · Cited by 1,278
Long-term persistence in use of statin therapy in elderly patients
Benner, J. S. (2002) · JAMA · doi:10.1001/jama.288.4.455 · Cited by 1,232
Aspirin and the Risk of Colorectal Cancer in Women
Giovannucci, E., Egan, K. M., Hunter, D. J., Stampfer, M. J., Colditz, G. A., Willett, W. C., & Speizer, F. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509073331001 · Cited by 1,090
Grodstein, F., Manson, J. E., Colditz, G. A., Willett, W. C., Speizer, F. E., & Stampfer, M. J. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-12-200012190-00008 · Cited by 1,063 · cited 1×
“For example, randomized trials showed an initial harmful cardiovascular effect of hormone replacement therapy (HRT) [112,113], whereas observational studies failed to uncover these initial risks [114].”
BackgroundBIAS DUE TO MISCLASSIFICATION IN THE ESTIMATION OF RELATIVE RISK
COPELAND, K. T., CHECKOWAY, H., McMICHAEL, A. J., & HOLBROOK, R. H. (1977) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112408 · Cited by 1,000
Adverse Events Associated With Prescription Drug Cost-Sharing Among Poor and Elderly Persons
Tamblyn, R. (2001) · JAMA · doi:10.1001/jama.285.4.421 · Cited by 873
Cepeda, M. S. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg115 · Cited by 859 · cited 1×
“Because exposure propensity scores model the relation of covariates and their interactions with the exposure and not directly with the study outcomes, such study configurations are ideal for applying EPS to avoid the risk of over-fitting if there were fewer than 10 outcomes per variable in a traditional outcome model…”
Jick, H., Jick, S. S., & Derby, L. E. (1991) · BMJ · doi:10.1136/bmj.302.6779.766 · Cited by 839
Simulation-Extrapolation Estimation in Parametric Measurement Error Models
Cook, J. R., & Stefanski, L. A. (1994) · Journal of the American Statistical Association · doi:10.1080/01621459.1994.10476871 · Cited by 792
Schneeweiss, S. (2001) · American Journal of Epidemiology · doi:10.1093/aje/154.9.854 · Cited by 711
Self-citationThe accuracy of Medicare's hospital claims data: progress has been made, but problems remain.
Fisher, E. S., Whaley, F. S., Krushat, W. M., Malenka, D. J., Fleming, C., Baron, J. A., & Hsia, D. C. (1992) · American Journal of Public Health · doi:10.2105/ajph.82.2.243 · Cited by 709
ECONOMETRICS IN OUTCOMES RESEARCH: The Use of Instrumental Variables
Newhouse, J. P., & McClellan, M. (1998) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.19.1.17 · Cited by 676
Association of road-traffic accidents with benzodiazepine use
Barbone, F., McMahon, A., Davey, P., Morris, A., Reid, I., McDevitt, D., & MacDonald, T. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04087-2 · Cited by 559
When are observational studies as credible as randomised trials?
Vandenbroucke, J. P. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16261-2 · Cited by 538
Kiyota, Y., Schneeweiss, S., Glynn, R. J., Cannuscio, C. C., Avorn, J., & Solomon, D. H. (2004) · American Heart Journal · doi:10.1016/j.ahj.2004.02.013 · Cited by 531
Self-citationSolomon, D. H., Schneeweiss, S., Glynn, R. J., Kiyota, Y., Levin, R., Mogun, H., & Avorn, J. (2004) · Circulation · doi:10.1161/01.cir.0000127578.21885.3e · Cited by 509
Self-citationEffects of Medicaid Drug-Payment Limits on Admission to Hospitals and Nursing Homes
Soumerai, S. B., Ross-Degnan, D., Avorn, J., McLaughlin, T. J., & Choodnovskiy, I. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110103251505 · Cited by 505
Self-citation(2003) · PubMed · Cited by 490
Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction
Soumerai, S. B. (1997) · JAMA · doi:10.1001/jama.277.2.115 · Cited by 486
ROSNER, B., SPIEGELMAN, D., & WILLETT, W. C. (1990) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115715 · Cited by 464
A framework for evaluation of secondary data sources for epidemiological research
SØRENSEN, H. T., SABROE, S., & OLSEN, J. (1996) · International Journal of Epidemiology · doi:10.1093/ije/25.2.435 · Cited by 455
Validation of diagnostic codes within medical services claims
Wilchesky, M., Tamblyn, R. M., & Huang, A. (2004) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(03)00246-4 · Cited by 439
Acute respiratory-tract infections and risk of first-time acute myocardial infarction
Meier, C. R., Jick, S. S., Derby, L. E., Vasilakis, C., Jick, H., Meier, C., Jick, S., Derby, L., Vasilakis, C., & Jick, H. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11084-4 · Cited by 389
Relative Incidence Estimation from Case Series for Vaccine Safety Evaluation
Farrington, C. P. (1995) · Biometrics · doi:10.2307/2533328 · Cited by 367
Rare Outcomes, Common Treatments: Analytic Strategies Using Propensity Scores
Braitman, L. E., & Rosenbaum, P. R. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-8-200210150-00015 · Cited by 364
Assessment and Control for Confounding by Indication in Observational Studies
Psaty, B. M., Koepsell, T. D., Lin, D., Weiss, N. S., Siscovick, D. S., Rosendaal, F. R., Pahor, M., & Furberg, C. D. (1999) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1999.tb01603.x · Cited by 363
Recall Accuracy for Prescription Medications: Self-report Compared with Database Information
West, S. L., Savitz, D. A., Koch, G., Strom, B. L., Guess, H. A., & Hartzema, A. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117563 · Cited by 352
STRATIFICATION BY A MULTIVARIATE CONFOUNDER SCORE
MIETTINEN, O. S. (1976) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112339 · Cited by 348
Bias in the Coding of Hospital Discharge Data and Its Implications for Quality Assessment
Romano, P. S., & Mark, D. H. (1994) · Medical Care · doi:10.1097/00005650-199401000-00006 · Cited by 346
Principles for modeling propensity scores in medical research: a systematic literature review
Weitzen, S., Lapane, K. L., Toledano, A. Y., Hume, A. L., & Mor, V. (2004) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.969 · Cited by 344
MCCLELLAN, M., MCNEIL, B. J., & NEWHOUSE, J. P. (1995) · Survey of Anesthesiology · doi:10.1097/00132586-199506000-00003 · Cited by 331
Understanding the Divergent Data on Postmenopausal Hormone Therapy
Grodstein, F., Clarkson, T. B., & Manson, J. E. (2003) · New England Journal of Medicine · doi:10.1056/nejmsb022365 · Cited by 329
Mortality in Current and Former Users of Clozapine
Walker, A. M., Lanza, L. L., Arellano, F., & Rothman, K. J. (1997) · Epidemiology · doi:10.1097/00001648-199710000-00010 · Cited by 328
Simulation-Extrapolation: The Measurement Error Jackknife
Stefanski, L. A., & Cook, J. R. (1995) · Journal of the American Statistical Association · doi:10.1080/01621459.1995.10476629 · Cited by 327
Ray, W. A., Stein, C. M., Hall, K., Daugherty, J. R., & Griffin, M. R. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07370-1 · Cited by 326
Shapiro, S. (1997) · PubMed · Cited by 299
Hallas, J. (1996) · Epidemiology · doi:10.1097/00001648-199609000-00005 · Cited by 289
Mamdani, M., Rochon, P., Juurlink, D. N., Anderson, G. M., Kopp, A., Naglie, G., Austin, P. C., & Laupacis, A. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.4.481 · Cited by 281
The need for randomization in the study of intended effects
Miettinen, O. S. (1983) · Statistics in Medicine · doi:10.1002/sim.4780020222 · Cited by 277
Suissa, S. (1995) · Epidemiology · doi:10.1097/00001648-199505000-00010 · Cited by 270
Semi-Automated Sensitivity Analysis to Assess Systematic Errors in Observational Data
Lash, T. L., & Fink, A. K. (2003) · Epidemiology · doi:10.1097/01.ede.0000071419.41011.cf · Cited by 250
Stürmer, T., Schneeweiss, S., Avorn, J., & Glynn, R. J. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi192 · Cited by 232
Self-citationHubbard, R. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg114 · Cited by 197
Powerful medicines: the benefits, risks, and costs of prescription drugs
(2005) · Choice Reviews Online · doi:10.5860/choice.42-5297a · Cited by 191
Medicaid data as a resource for epidemiologic studies: Strengths and limitations
Bright, R. A., Avorn, J., & Everitt, D. E. (1989) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(89)90158-3 · Cited by 187
Self-citationParadoxical Relations of Drug Treatment with Mortality in Older Persons
Glynn, R. J., Knight, E. L., Levin, R., & Avorn, J. (2001) · Epidemiology · doi:10.1097/00001648-200111000-00017 · Cited by 181
Self-citationOutcomes of Reference Pricing for Angiotensin-Converting–Enzyme Inhibitors
Schneeweiss, S., Walker, A. M., Glynn, R. J., Maclure, M., Dormuth, C., & Soumerai, S. B. (2002) · New England Journal of Medicine · doi:10.1056/nejmsa003087 · Cited by 178
Self-citationA Critical Analysis of Studies of State Drug Reimbursement Policies: Research in Need of Discipline
Soumerai, S. B., Ross-Degnan, D., Fortess, E. E., & Abelson, J. (1993) · The Milbank Quarterly · doi:10.2307/3350399 · Cited by 169
The role of databases in drug postmarketing surveillance
Rodriguez, E. M., Staffa, J. A., & Graham, D. J. (2001) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.615 · Cited by 165
Gatsonis, C. A., Epstein, A. M., Newhouse, J. P., Normand, S.-L., & McNeil, B. J. (1995) · MEDICAL CARE · doi:10.1097/00005650-199506000-00005 · Cited by 163
McClellan, M. (1994) · JAMA · doi:10.1001/jama.272.11.859 · Cited by 163
Quality Indicators for Appropriate Medication Use in Vulnerable Elders
Knight, E. L., & Avorn, J. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-8_part_2-200110161-00009 · Cited by 157
Self-citationApplied longitudinal data analysis for epidemiology:
Montgomery, S. (2005) · European Journal of Epidemiology · doi:10.1007/s10654-004-3142-1 · Cited by 150
Daviglus, M. L., Dyer, A. R., Persky, V., Chávez, N., Drum, M. L., Goldberg, J., Liu, K., Morris, D. K., Shekelle, R. B., & Stamler, J. (1996) · Epidemiology · doi:10.1097/00001648-199609000-00004 · Cited by 144
Ray, W. A., Stein, C., & Halla, K. (2002) · ACC Current Journal Review · doi:10.1016/s1062-1458(02)00687-6 · Cited by 140
Tamblyn, R. M., McLeod, P. J., Hanley, J. A., Girard, N., & Hurley, J. (2003) · Medical Care · doi:10.1097/00005650-200308000-00004 · Cited by 140
Martin, R. (2001) · International Journal of Epidemiology · doi:10.1093/ije/30.4.911 · Cited by 139
Causation of Bias: The Episcope
Maclure, M., & Schneeweiß, S. (2001) · Epidemiology · doi:10.1097/00001648-200101000-00019 · Cited by 128
Identifying a Short Functional Disability Screen for Older Persons
Saliba, D., Orlando, M., Wenger, N. S., Hays, R. D., & Rubenstein, L. Z. (2000) · The Journals of Gerontology Series A · doi:10.1093/gerona/55.12.m750 · Cited by 127
(1995) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(95)00530-7 · Cited by 123
Schneeweiß, S., Glynn, R. J., Tsai, E. H., Avorn, J., & Solomon, D. H. (2004) · Epidemiology · doi:10.1097/01.ede.0000147164.11879.b5 · Cited by 119
Self-citationCook, E. F., & Goldman, L. (1989) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(89)90036-x · Cited by 114
Brenner, H., & Gefeller, O. (1993) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116805 · Cited by 114
Assessing accuracy of diagnosis-type indicators for flagging complications in administrative data
Quan, H., Parsons, G. A., & Ghali, W. A. (2004) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2003.01.002 · Cited by 112
The Waiting Time Distribution as a Graphical Approach to Epidemiologic Measures of Drug Utilization
Hallas, J., Gaist, D., & Bjerrum, L. (1997) · Epidemiology · doi:10.1097/00001648-199710000-00009 · Cited by 100
Suissa, S. (1998) · Epidemiology · doi:10.1097/00001648-199807000-00016 · Cited by 91
Data validity issues in using claims data
Strom, B. L. (2001) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.610 · Cited by 90
Schneeweiß, S., & Wang, P. S. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000145344.76288.39 · Cited by 87
Platt, R. G., Davis, R. L., Finkelstein, J. A., Go, A. S., Gurwitz, J. H., Roblin, D. W., Soumerai, S. B., Ross‐Degnan, D., Andrade, S., Goodman, M. J., et al. (2001) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.607 · Cited by 83
Agreement between GPRD smoking data: a survey of general practitioners and a population‐based survey
Lewis, J. D., & Brensinger, C. (2004) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.902 · Cited by 80 · cited 1×
“, 78% sensitivity for current smoking [60% former smoking] in the General Practice Research Database) [34] or missing for large proportions of the population (e.”
BackgroundWest, S. L., Strom, B. L., Freundlich, B., Normand, E. H., Koch, G. G., & Savitz, D. A. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90021-3 · Cited by 79
The case-time-control design: further assumptions and conditions.
Suissa, S. (1998) · PubMed · Cited by 77
Schneeweiß, S., Glynn, R. J., Avorn, J., & Solomon, D. H. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2004.06.002 · Cited by 74
Self-citationPost-marketing studies of drug efficacy: Why?
Strom, B. L., Melmon, K. L., & Miettinen, O. S. (1985) · The American Journal of Medicine · doi:10.1016/0002-9343(85)90341-9 · Cited by 74
Churn, churn, churn: how instability of health insurance shapes America's uninsured problem.
Short, P. F., Graefe, D. R., & Schoen, C. (2003) · PubMed · Cited by 71
Descriptive analyses of the integrity of a US Medicaid claims database
Hennessy, S., Bilker, W. B., Weber, A. L., & Strom, B. L. (2003) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.765 · Cited by 71
THE EFFECT OF MISCLASSIFICATION IN MATCHED-PAIR CASE-CONTROL STUDIES
Greenland, S. (1982) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113424 · Cited by 69
Matching MCBS (Medicare Current Beneficiary Survey) and Medicare data: the best of both worlds.
Eppig, F. J., & Chulis, G. S. (1997) · PubMed · Cited by 65
The impact of wording in “Dear doctor” letters and in black box labels
Weatherby, L. B. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.129503 · Cited by 65
Within‐subject exposure dependency in case‐crossover studies
Vines, S. K., & Farrington, P. (2001) · Statistics in Medicine · doi:10.1002/sim.960 · Cited by 65
McKenzie, D. A., Semradek, J. A., McFarland, B. H., Mullooly, J. P., & McCamant, L. E. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00259-6 · Cited by 64
MILLER, D. P., Alfredson, T. D., Cook, S. F., Sands, B. E., & Walker, A. M. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07418.x · Cited by 61
Guess, H. A. (1989) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(89)90116-9 · Cited by 58
Relative Excess Risk: An Alternative Measure of Comparative Risk
Suissa, S. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009999 · Cited by 55
Schneeweiß, S., Schöffski, O., & Selke, G. (1998) · Health Policy · doi:10.1016/s0168-8510(98)00023-2 · Cited by 48
Schneeweiß, S., Maclure, M., Soumerai, S. B., Walker, A. M., & Glynn, R. J. (2002) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(02)00437-7 · Cited by 44
Powerful Medicines: The Benefits, Risks, and Costs of Prescription Drugs
Meyer, B. R. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-1-200501040-00024 · Cited by 43
Use of the case-crossover design to study prolonged drug exposures and insidious outcomes
Wang, P. S., Schneeweiß, S., Glynn, R. J., Mogun, H., & Avorn, J. (2004) · Annals of Epidemiology · doi:10.1016/j.annepidem.2003.09.012 · Cited by 43
Self-citationMcMahon, A. D., Evans, J. M. M., McGilchrist, M. M., McDevitt, D. G., & MacDonald, T. M. (1998) · Pharmacoepidemiology and Drug Safety · Cited by 37
Post-marketing studies of drug efficacy: How?
Strom, B. L., Miettinen, O. S., & Melmon, K. L. (1984) · The American Journal of Medicine · doi:10.1016/0002-9343(84)90369-3 · Cited by 36
Risk assessment of drugs, biologics and therapeutic devices: present and future issues
Strom, B. L. (2003) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.859 · Cited by 35
Record Linkage Studies for Postmarketing Drug Surveillance: Data Quality and Validity Considerations
Stergachis, A. S. (1988) · Annals of Pharmacotherapy · doi:10.1177/106002808802200216 · Cited by 33
Greenland, S., & Finkle, W. D. (2000) · Annals of Epidemiology · doi:10.1016/s1047-2797(00)00037-5 · Cited by 29
Levy, A. R., Tamblyn, R. M., McLeod, P. J., Fitchett, D., & Abrahamowicz, M. (2002) · Annals of Epidemiology · doi:10.1016/s1047-2797(01)00251-4 · Cited by 14
Cited by
Quan, H., Li, B., Couris, C. M., Fushimi, K., Graham, P., Hider, P., Januel, J.-M., & Sundararajan, V. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwq433 · Cited by 5,843
Interpretation of the evidence for the efficacy and safety of statin therapy
Collins, R., Reith, C., Emberson, J., Armitage, J., Baigent, C., Blackwell, L., Blumenthal, R., Danesh, J., Smith, G. D., DeMets, D., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31357-5 · Cited by 1,857
Data Resource Profile: The Danish National Prescription Registry
Pottegård, A., Schmidt, S. A. J., Wallach-Kildemoes, H., Sørensen, H. T., Hallas, J., & Schmidt, M. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw213 · Cited by 1,431
Schneeweiss, S., Rassen, J. A., Glynn, R. J., Avorn, J., Mogun, H., & Brookhart, M. A. (2009) · Epidemiology · doi:10.1097/ede.0b013e3181a663cc · Cited by 1,128
Self-citationA combined comorbidity score predicted mortality in elderly patients better than existing scores
Gagne, J. J., Glynn, R. J., Avorn, J., Levin, R., & Schneeweiss, S. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.10.004 · Cited by 995
Self-citation
Metadata
- Authors
- Schneeweiss, S., & Avorn, J.
- Venue
- Journal of Clinical Epidemiology
- Publisher
- Elsevier BV
- Published
- 2005-04
- Volume
- 58
- Issue
- 4
- Pages
- 323-337
- ISSN
- 0895-4356 (ISSN-L)
- OpenAlex
- W2053237747
- Cited by
- 1,277
- References
- 109
- FWCI
- 43.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.